Results 51 to 60 of about 27,167 (183)

Intravenous Tolvaptan Sodium Phosphate Can Fail to Improve Fluid Overload Due to Heart Failure in Patients With Chronic Kidney Disease: A Case Report

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT Tolvaptan is widely used as an adjunct oral diuretic to loop and thiazide diuretics for the management of fluid overload in patients with congestive heart failure. Recently, tolvaptan sodium phosphate (TSP), a water‐soluble prodrug of tolvaptan, was developed for intravenous administration and has demonstrated efficacy and safety in clinical ...
Takaya Uno   +10 more
wiley   +1 more source

Safe Percutaneous Dilatational Tracheostomy Using a Pre‐Measured Light‐Guided Endotracheal Tube Withdrawal Technique: A Case Report

open access: yesRespirology Case Reports, Volume 14, Issue 6, June 2026.
This report describes a practical adjunct to bronchoscopy‐guided percutaneous dilatational tracheostomy: a two‐step method in which an individualized endotracheal tube withdrawal distance is estimated using bronchoscopic transillumination and subsequently used as a quantitative target during tube repositioning, with real‐time confirmation at the ...
Yuya Aoki, Masaki Kono, Takuo Yoshida
wiley   +1 more source

The effect of nitroglycerin on forearm arterial distensibility.

open access: yes, 1986
Nitroglycerin acts, in part, to reduce arterial impedance, and thus left ventricular work. The reduction in arterial impedance is largely attributable to a fall in systemic vascular resistance, but may also be due to an increased distensibility of the ...
H Smulyan, R A Warner, S Mookherjee
core   +1 more source

Nrf2/NOX2 Pathway Dysregulation and Oxidative Stress Biomarkers in Gaucher Disease–Associated Parkinsonism: Insights Into a Potential Therapeutic Target

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 11, June 2026.
ABSTRACT Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder, yet its underlying genetic and molecular mechanisms remain incompletely understood. Variants in the GBA gene, encoding the lysosomal enzyme glucocerebrosidase, are not only responsible for Gaucher disease (GD) but also represent a significant genetic risk factor ...
Alessio Ardizzone   +8 more
wiley   +1 more source

Elevated ASGR1 as a Potential Diagnostic Biomarker for Coronary Artery Disease and Predictor of Adverse Outcomes in Hypertensive Patients

open access: yesThe FASEB Journal, Volume 40, Issue 9, 15 May 2026.
Asialoglycoprotein receptor 1 (ASGR1) is linked to lipid metabolism and CAD, but its role in hypertensive CAD patients is unclear. This single‐center study included 345 hypertensive patients (59 non‐CAD, 286 CAD). Plasma ASGR1 was higher in CAD patients, correlated with multiple markers and HDL‐C, had high diagnostic value (better than traditional ...
Ying Liu   +12 more
wiley   +1 more source

Effect of nitroglycerin administration on cardio-ankle vascular index

open access: yes, 2016
Kazuhiro Shimizu,1 Tomoyuki Yamamoto,2,3 Mao Takahashi,1 Shuji Sato,1 Hirofumi Noike,1 Kohji Shirai2 1Department of Internal Medicine, 2Department of Vascular Function, Toho University Sakura Medical Center, Chiba, 3Biological Information Analysis ...
Sato S   +5 more
core  

Meta-analysis: Nitroglycerin for prevention of post-ERCP pancreatitis

open access: yes, 2009
Udgivelsesdato: 2009-May-15BACKGROUND: Acute pancreatitis after ERCP is a severe side effect. AIM: To evaluate the preventive effect of nitroglycerin on post-ERCP pancreatitis by a meta-analysis of randomized clinical studies.
Andersen, P K   +5 more
core   +1 more source

Nitroglycerin Ointment in the Treatment of Impotence

open access: yes, 1993
Topical nitroglycerin ointment has been studied in the laboratory as a possible treatment for impotence of various etiologies. However, there is limited information on the topical administration of nitroglycerin in a natural environment allowing normal ...
Nunez, B. D., Anderson, Douglas C.
core  

Interactions of nitroglycerin and sulfhydryl-donating compounds in coronary microvessels

open access: yes, 1994
Previous studies have shown the effect of nitroglycerin on coronary microvessels < 100 microns in diameter is markedly enhanced by L-cysteine. These studies were performed to examine the mechanisms responsible for this effect.
S. P. Dockery   +4 more
core   +1 more source

Altered peripheral vesodilator profile of nitroglycerin during long-term infusion of N-acetylcysteine

open access: yes, 1994
Objectives. The aim of this study was to compare the short- and long-term effects of intravenous nitroglycerin plus placebo and nitroglycerin plus N-acetylcysteine on peripheral arteries, veins and microcirculation in humans.Background. The thiol donor N-
Wroblewski, Henrik   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy